Reagents (2)

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Reference: R1011-1

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

SGX-523

Reference: A1196-5.1

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

HT-2 Toxin-13C22

Reference: 31299-1,2

€0.00 (tax incl.)

An internal standard for the quantification of HT-2 toxin by GC- or LC-MS

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Reference: R1011-5

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

SGX-523

Reference: A1196-25

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

T-2 Toxin-13C24

Reference: 31300-1,2

€0.00 (tax incl.)

An internal standard for the quantification of T-2 toxin by GC- or LC-MS

Firefly Luciferase mRNA (ARCA, 5-moUTP)

Reference: R1012-.1

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

SGX-523

Reference: A1196-100

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

Patulin-13C7

Reference: 31301-1,2

€0.00 (tax incl.)

An internal standard for the quantification of patulin by GC- or LC-MS

Firefly Luciferase mRNA (ARCA, 5-moUTP)

Reference: R1012-1

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

Levetiracetam

Reference: A1198-50

€0.00 (tax incl.)

Antiepileptic drug

Sterigmatocystin-13C18

Reference: 31302-1,2

€0.00 (tax incl.)

An internal standard for the quantification of sterigmatocystin by GC- or LC-MS,,

Firefly Luciferase mRNA (ARCA, 5-moUTP)

Reference: R1012-5

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

Levetiracetam

Reference: A1198-5.1

€0.00 (tax incl.)

Antiepileptic drug

Adefovir-d4

Reference: 31315-2,5

€0.00 (tax incl.)

An internal standard for the quantification of adefovir by GC- or LC-MS

EZ Cap™ Firefly Luciferase mRNA (5-moUTP)

Reference: R1013-.1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

Levetiracetam

Reference: A1198-100

€0.00 (tax incl.)

Antiepileptic drug

Eplerenone-d3

Reference: 31610-2,5

€0.00 (tax incl.)

An internal standard for the quantification of eplerenone by GC- or LC-MS

EZ Cap™ Firefly Luciferase mRNA (5-moUTP)

Reference: R1013-1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

Daptomycin

Reference: A1206-5.1

€0.00 (tax incl.)

Calcium-dependent antibiotic

Cyclopentenone Prostaglandin HPLC Mixture

Reference: 10000-1

€0.00 (tax incl.)

This mixture contains all of the major UV-absorbing cyclopentenone prostaglandins and their precursors. Contents:,100 µg of each compound, Prostaglandin A2 (Item No. 10210),Prostaglandin B2 (Item No. 11210)...

EZ Cap™ Firefly Luciferase mRNA (5-moUTP)

Reference: R1013-5

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

Daptomycin

Reference: A1206-25

€0.00 (tax incl.)

Calcium-dependent antibiotic

Vasoactive Eicosanoid HPLC Mixture

Reference: 10003-1

€0.00 (tax incl.)

This mixture contains the characteristic metabolites of both PGI2 and TXA2. Contents: Thromboxane B2, 11-dehydro Thromboxane B2, 6-keto Prostaglandin F1α, 2,3-dinor-6-keto Prostaglandin F1α (100 µg each), and...

EZ Cap™ Cas9 mRNA (5-moUTP)

Reference: R1015-.1

€0.00 (tax incl.)

Used with guideRNA for site-specific DNA cleavage in genome editing.

Daptomycin

Reference: A1206-100

€0.00 (tax incl.)

Calcium-dependent antibiotic

4-oxo-2-Nonenal-d3

Reference: 10004174-1

€0.00 (tax incl.)

4-ONE-d3 contains three deuterium atoms at the terminal methyl position. It is intended for use as an internal standard for the quantification of 4-ONE by GC- or LC-MS.

EZ Cap™ Cas9 mRNA (5-moUTP)

Reference: R1015-1

€0.00 (tax incl.)

Used with guideRNA for site-specific DNA cleavage in genome editing.

Lansoprazole

Reference: A1229-1000

€0.00 (tax incl.)

H+,K+-ATPase inhibitor

4-oxo-2-Nonenal-d3

Reference: 10004174-100

€0.00 (tax incl.)

4-ONE-d3 contains three deuterium atoms at the terminal methyl position. It is intended for use as an internal standard for the quantification of 4-ONE by GC- or LC-MS.

EZ Cap™ Cas9 mRNA (5-moUTP)

Reference: R1015-5

€0.00 (tax incl.)

Used with guideRNA for site-specific DNA cleavage in genome editing.

Lansoprazole

Reference: A1229-5.1

€0.00 (tax incl.)

H+,K+-ATPase inhibitor

4-oxo-2-Nonenal-d3

Reference: 10004174-50

€0.00 (tax incl.)

4-ONE-d3 contains three deuterium atoms at the terminal methyl position. It is intended for use as an internal standard for the quantification of 4-ONE by GC- or LC-MS.

EZ Cap™ EGFP mRNA (5-moUTP)

Reference: R1016-.1

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

WYE-354

Reference: A1266-5

€0.00 (tax incl.)

MTOR inhibitor,potent,ATP-competitive and cell-permeable

4-oxo-2-Nonenal-d3

Reference: 10004174-500

€0.00 (tax incl.)

4-ONE-d3 contains three deuterium atoms at the terminal methyl position. It is intended for use as an internal standard for the quantification of 4-ONE by GC- or LC-MS.

EZ Cap™ EGFP mRNA (5-moUTP)

Reference: R1016-1

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

WYE-354

Reference: A1266-10

€0.00 (tax incl.)

MTOR inhibitor,potent,ATP-competitive and cell-permeable

Prostaglandin E2-1-glyceryl ester-d5

Reference: 10004197-100

€0.00 (tax incl.)

An internal standard for the quantification of PGE2-1-glyceryl ester by GC- or LC-MS

EZ Cap™ EGFP mRNA (5-moUTP)

Reference: R1016-5

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

WYE-354

Reference: A1266-25

€0.00 (tax incl.)

MTOR inhibitor,potent,ATP-competitive and cell-permeable

Prostaglandin E2-1-glyceryl ester-d5

Reference: 10004197-50

€0.00 (tax incl.)

An internal standard for the quantification of PGE2-1-glyceryl ester by GC- or LC-MS

EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

Reference: R1017-.1

€0.00 (tax incl.)

mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

WYE-354

Reference: A1266-50

€0.00 (tax incl.)

MTOR inhibitor,potent,ATP-competitive and cell-permeable

Prostaglandin E2-1-glyceryl ester-d5

Reference: 10004197-500

€0.00 (tax incl.)

An internal standard for the quantification of PGE2-1-glyceryl ester by GC- or LC-MS

EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

Reference: R1017-1

€0.00 (tax incl.)

mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

Adapalene

Reference: A1267-50

€0.00 (tax incl.)

RARβ and RARγ agonist

Prostaglandin Metabolite HPLC Mixture

Reference: 10005-1

€0.00 (tax incl.)

This mixture contains the primary metabolites of PGD2, PGE2, and PGF2α. Contents: 13,14-dihydro-15-keto PGD2, 13,14-dihydro-15-keto PGE2, 11β-PGF2α, 13,14-dihydro-15-keto PGF2α, and PGF2β (100 µg each).

EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

Reference: R1017-5

€0.00 (tax incl.)

mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

Adapalene

Reference: A1267-5.1

€0.00 (tax incl.)

RARβ and RARγ agonist

Eicosapentaenoic Acid-d5

Reference: 10005056-1

€0.00 (tax incl.)

An internal standard for the quantification of EPA by GC- or LC-MS

EZ Cap™ Firefly Luciferase mRNA

Reference: R1018-.1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.

Adapalene

Reference: A1267-100

€0.00 (tax incl.)

RARβ and RARγ agonist

Eicosapentaenoic Acid-d5

Reference: 10005056-100

€0.00 (tax incl.)

An internal standard for the quantification of EPA by GC- or LC-MS

Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO)

Reference: K1024-1

€0.00 (tax incl.)

Inhibit proteolytic degradation during bacterium lysis and protein extraction

EZ Cap™ Firefly Luciferase mRNA

Reference: R1018-1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.

Granisetron HCl

Reference: A1295-5

€0.00 (tax incl.)

5-HT3 receptor antagonist

Eicosapentaenoic Acid-d5

Reference: 10005056-50

€0.00 (tax incl.)

An internal standard for the quantification of EPA by GC- or LC-MS

Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO)

Reference: K1024-20

€0.00 (tax incl.)

Inhibit proteolytic degradation during bacterium lysis and protein extraction

EZ Cap™ Firefly Luciferase mRNA

Reference: R1018-5

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.

Granisetron HCl

Reference: A1295-50

€0.00 (tax incl.)

5-HT3 receptor antagonist

Eicosapentaenoic Acid-d5

Reference: 10005056-500

€0.00 (tax incl.)

An internal standard for the quantification of EPA by GC- or LC-MS

ARCA EGFP mRNA

Reference: R1001-.1

€0.00 (tax incl.)

Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.

Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO)

Reference: K1024-50

€0.00 (tax incl.)

Inhibit proteolytic degradation during bacterium lysis and protein extraction

Granisetron HCl

Reference: A1295-100

€0.00 (tax incl.)

5-HT3 receptor antagonist

Docosahexaenoic Acid-d5

Reference: 10005057-1

€0.00 (tax incl.)

An internal standard for the quantification of DHA by GC- or LC-MS

ARCA EGFP mRNA

Reference: R1001-1

€0.00 (tax incl.)

Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.

Protease Inhibitor Cocktail for bacterial cell extracts (100 X in DMSO)

Reference: K1024-100

€0.00 (tax incl.)

Inhibit proteolytic degradation during bacterium lysis and protein extraction

Exemestane

Reference: A1296-10

€0.00 (tax incl.)

Steroidal aromatase inhibitor,selective and irreversible

Docosahexaenoic Acid-d5

Reference: 10005057-100

€0.00 (tax incl.)

An internal standard for the quantification of DHA by GC- or LC-MS

ARCA EGFP mRNA

Reference: R1001-5

€0.00 (tax incl.)

Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.

Exemestane

Reference: A1296-5.1

€0.00 (tax incl.)

Steroidal aromatase inhibitor,selective and irreversible

Docosahexaenoic Acid-d5

Reference: 10005057-50

€0.00 (tax incl.)

An internal standard for the quantification of DHA by GC- or LC-MS

EZ Cap™ EPO mRNA (ψUTP)

Reference: R1020-.1

€0.00 (tax incl.)

Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.

Exemestane

Reference: A1296-25

€0.00 (tax incl.)

Steroidal aromatase inhibitor,selective and irreversible

Docosahexaenoic Acid-d5

Reference: 10005057-500

€0.00 (tax incl.)

An internal standard for the quantification of DHA by GC- or LC-MS

EZ Cap™ EPO mRNA (ψUTP)

Reference: R1020-1

€0.00 (tax incl.)

Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.

Exemestane

Reference: A1296-100

€0.00 (tax incl.)

Steroidal aromatase inhibitor,selective and irreversible

PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt)

Reference: 10005615-100

€0.00 (tax incl.)

An internal standard for the quantification of PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (sodium salt) by GC- or LC-MS.

EZ Cap™ EPO mRNA (ψUTP)

Reference: R1020-5

€0.00 (tax incl.)

Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.

GSK1904529A

Reference: A1302-S

€0.00 (tax incl.)

Selective IGF-1R/IR inhibitor

PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt)

Reference: 10005615-25

€0.00 (tax incl.)

An internal standard for the quantification of PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (sodium salt) by GC- or LC-MS.

GSK1904529A

Reference: A1302-10

€0.00 (tax incl.)

Selective IGF-1R/IR inhibitor

PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt)

Reference: 10005615-50

€0.00 (tax incl.)

An internal standard for the quantification of PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (sodium salt) by GC- or LC-MS.

GSK1904529A

Reference: A1302-5.1

€0.00 (tax incl.)

Selective IGF-1R/IR inhibitor

PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt)

Reference: 10005616-100

€0.00 (tax incl.)

An internal standard for the quantification of PtdIns-(3)-P1 (1,2-dipalmitoyl) (ammonium salt) by GC- or LC-MS.

GSK1904529A

Reference: A1302-50

€0.00 (tax incl.)

Selective IGF-1R/IR inhibitor

PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt)

Reference: 10005616-25

€0.00 (tax incl.)

An internal standard for the quantification of PtdIns-(3)-P1 (1,2-dipalmitoyl) (ammonium salt) by GC- or LC-MS.

Letrozole

Reference: A1307-5.1

€0.00 (tax incl.)

Non-steroidal aromatase inhibitor

PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt)

Reference: 10005616-50

€0.00 (tax incl.)

An internal standard for the quantification of PtdIns-(3)-P1 (1,2-dipalmitoyl) (ammonium salt) by GC- or LC-MS.

Letrozole

Reference: A1307-100

€0.00 (tax incl.)

Non-steroidal aromatase inhibitor

Leukotriene A4-d5 methyl ester

Reference: 10006197-100

€0.00 (tax incl.)

An internal standard for the quantification of LTA4 methyl ester by GC- or LC-MS

Gatifloxacin

Reference: A1313-1000

€0.00 (tax incl.)

Fluoroquinolone antibiotic,inhibits bacterial TOPO II

Leukotriene A4-d5 methyl ester

Reference: 10006197-25

€0.00 (tax incl.)

An internal standard for the quantification of LTA4 methyl ester by GC- or LC-MS

Gatifloxacin

Reference: A1313-5000

€0.00 (tax incl.)

Fluoroquinolone antibiotic,inhibits bacterial TOPO II

Leukotriene A4-d5 methyl ester

Reference: 10006197-50

€0.00 (tax incl.)

An internal standard for the quantification of LTA4 methyl ester by GC- or LC-MS

Mosapride Citrate

Reference: A1334-10

€0.00 (tax incl.)

5-HT receptor agonist

Leukotriene C4-d5

Reference: 10006198-100

€0.00 (tax incl.)

An internal standard for the quantification of LTC4 by GC- or LC-MS

Mosapride Citrate

Reference: A1334-5.1

€0.00 (tax incl.)

5-HT receptor agonist

Leukotriene C4-d5

Reference: 10006198-25

€0.00 (tax incl.)

An internal standard for the quantification of LTC4 by GC- or LC-MS

Category: Reagents

Menu

Settings